The AI engine Fit Assessment
BetaFasttrac leverages machine learning and advanced computational methods to discover novel molecules, optimizing the drug discovery process and expanding therapeutic options.
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
Our computational Software as a Service (SaaS), Platform as a Service (PaaS) and Technology as a Service (TaaS) platform is capable of predicting critical properties of molecules with a high degree of accuracy. This critical capability enables drug discovery teams to design and selectively synthesize molecules with more optimal properties, reducing the average time and costs required to identify a development candidate and increasing the probability that a drug discovery program will enter clinical development.